Bone Biologics Corporatio...

NASDAQ: BBLG · Real-Time Price · USD
2.21
-0.14 (-5.96%)
At close: Aug 15, 2025, 3:39 PM

Bone Biologics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
2.75M 3.33M 3.57M 2.33M 3.23M 3.03M 4.45M 7.01M 6.19M 7.54M 5.06M 5.45M 5.81M 6.68M 3.37K 4.44K 71.17K
Short-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Receivables
n/a n/a n/a n/a 328.84K 328.84K n/a n/a n/a 579.91K n/a n/a n/a n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a -328.84K -328.84K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Assets
415.5K n/a n/a n/a 328.84K 328.84K n/a n/a n/a n/a n/a n/a n/a n/a 49.02K n/a n/a
Total Current Assets
3.16M 3.86M 4.07M 3.19M 3.84M 3.74M 4.98M 7.62M 6.78M 8.5M 5.2M 5.66M 6.09M 6.68M 52.39K 4.44K 71.17K
Property-Plant & Equipment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Assets
3.16M 3.86M 4.07M 3.19M 3.84M 3.74M 4.98M 7.62M 6.78M 8.5M 5.2M 5.66M 6.09M 6.68M 52.39K 4.44K 71.17K
Account Payables
n/a 373.04K 190.06K 231.87K 146.19K 360.66K 1.1M 1.69M 2.28M 104.79K 799.48K 70.64K 54.91K 99.91K 70.28K 84.24K 503.34K
Deferred Revenue
n/a n/a n/a 44.98K n/a n/a n/a n/a n/a 783.67K n/a n/a n/a n/a n/a n/a n/a
Short-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 12.77M 12.49M 11.92M
Other Current Liabilities
251.16K 4.67K 83.34K 7.66K 18.44K 470.74K 80.51K 241.16K 1.73M 1.66M n/a n/a n/a n/a n/a n/a n/a
Total Current Liabilities
251.16K 377.71K 273.4K 284.51K 164.63K 831.4K 1.18M 1.93M 4.01M 2.55M 799.48K 70.64K 54.91K 99.91K 15.18M 14.62M 14.2M
Long-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 2.41M 2.13M n/a
Total Long-Term Liabilities
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 2.41M 2.13M 2.27M
Total Liabilities
251.16K 377.71K 273.4K 284.51K 164.63K 831.4K 1.18M 1.93M 4.01M 2.55M 799.48K 70.64K 54.91K 99.91K 15.18M 14.62M 14.2M
Total Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 12.77M 12.49M 11.92M
Common Stock
3.27K 2.95K 2.1K 1.31K 1.02K 534.00 3.13K 3.13K 16.7K 15.3K 10.35K 10.35K 10.35K 10.35K 12.27K 30.68K 30.68K
Retained Earnings
-86.04M -85.02M -83.5M -82.56M -81.77M -80.91M -79.36M -77.44M -75.67M -71.96M -72.85M -71.63M -71.17M -70.48M -70.3M -69.79M -69.3M
Comprehensive Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Shareholders Equity
2.91M 3.48M 3.79M 2.91M 3.67M 2.91M 3.79M 5.69M 2.77M 5.95M 4.4M 5.59M 6.04M 6.58M -15.13M -14.62M -14.12M
Total Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a